BEAT
Heartbeam, Inc. Common StockstockNASDAQ
heartbeam developed a mhealth technology that is diagnostically equivalent to a cardiologist reading a patient's 12 lead ecg and examining the patient. it comprises a credit card size, 12 lead equivalent, ecg device and a cloud-based diagnostic expert system. studies designed by harvard medical school faculty have shown heartbeam performance to be equal or better than world class cardiologists in diagnosing a heart attack. the technology features personalized diagnostic thresholds and novel heart attack ecg markers from which the application can also help cardiologists locate a heart attack on a 3d model of the heart. heartbeam's icardiologist application utilizes artificial intelligence / machine learning to drive continuous improvements of the system's ability to provide patient analysis and improve the solution's predictive properties.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.41 | 2026-11-10 | -16.47% | 3.031 |
| 1M | 0.44 | 2026-10-16 | -21.78% | 1.805 |
| 3M | 0.50 | 2026-08-17 | -31.79% | 2.416 |
| 6M | 0.96 | 2026-05-18 | -64.45% | 2.172 |
| 1Y | 1.54 | 2025-11-17 | -77.85% | 1.847 |
| 2Y | 2.39 | 2024-11-18 | -85.73% | — |
| 5Y | 4.18 | 2021-11-17 | -91.84% | 1.117 |
Heartbeam, Inc. Common Stock (NASDAQ:BEAT) stock price today is $0.34, and today's volume is 953,488. BEAT is down 5.000% today. The 30 day average volume is 2.00M. BEAT market cap is $21.59M with 63.31M shares outstanding.
